Search research articles
Contact Us
Filters
Showing results (1-10 of 188) with videos related to
Page
of 19
Sort By:
Pediatric Transplantation
|
May 6, 2004
Detection and treatment of minimal residual disease in high-risk neuroblastoma
C Patrick Reynolds
Journal of the National Cancer Institute
|
March 7, 2002
Ras and Seppuku in neuroblastoma
C Patrick Reynolds
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2005
Tirapazamine cytotoxicity for neuroblastoma is p53 dependent
Bo Yang, C Patrick Reynolds
Methods in Molecular Medicine
|
May 20, 2005
Evaluating response to antineoplastic drug combinations in tissue culture models
C Patrick Reynolds, Barry J Maurer
Molecular Cancer Therapeutics
|
December 17, 2010
Antagonism of cytotoxic chemotherapy in neuroblastoma cell lines by 13-cis-retinoic acid is mediated by the antiapoptotic Bcl-2 family proteins
Michael D Hadjidaniel, C Patrick Reynolds
Biologics : Targets & Therapy
|
January 8, 2019
Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy
Michelle E Keyel, C Patrick Reynolds
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy
Min H Kang, C Patrick Reynolds
Cancer Research
|
August 4, 2004
Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators
Sandeep Batra, C Patrick Reynolds, Barry J Maurer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2003
Pyrazoloacridine is active in multidrug-resistant neuroblastoma cell lines with nonfunctional p53
Nino Keshelava, Denice Tsao-Wei, C Patrick Reynolds
Cancer Discovery
|
December 2, 2024
Characterization of Persister Cells Provides Insights into Mechanisms of Therapy Resistance in Neuroblastoma
Amber B Wolf, C Patrick Reynolds, Eveline Barbieri
Page
of 19
Search research articles
Search
Showing results (1-10 of 188) with videos related to
Sort By:
Page
of 19
Pediatric Transplantation
|
May 6, 2004
Detection and treatment of minimal residual disease in high-risk neuroblastoma
C Patrick Reynolds
Journal of the National Cancer Institute
|
March 7, 2002
Ras and Seppuku in neuroblastoma
C Patrick Reynolds
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2005
Tirapazamine cytotoxicity for neuroblastoma is p53 dependent
Bo Yang, C Patrick Reynolds
Methods in Molecular Medicine
|
May 20, 2005
Evaluating response to antineoplastic drug combinations in tissue culture models
C Patrick Reynolds, Barry J Maurer
Molecular Cancer Therapeutics
|
December 17, 2010
Antagonism of cytotoxic chemotherapy in neuroblastoma cell lines by 13-cis-retinoic acid is mediated by the antiapoptotic Bcl-2 family proteins
Michael D Hadjidaniel, C Patrick Reynolds
Biologics : Targets & Therapy
|
January 8, 2019
Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy
Michelle E Keyel, C Patrick Reynolds
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy
Min H Kang, C Patrick Reynolds
Cancer Research
|
August 4, 2004
Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators
Sandeep Batra, C Patrick Reynolds, Barry J Maurer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2003
Pyrazoloacridine is active in multidrug-resistant neuroblastoma cell lines with nonfunctional p53
Nino Keshelava, Denice Tsao-Wei, C Patrick Reynolds
Cancer Discovery
|
December 2, 2024
Characterization of Persister Cells Provides Insights into Mechanisms of Therapy Resistance in Neuroblastoma
Amber B Wolf, C Patrick Reynolds, Eveline Barbieri
Page
of 19